Top Markets
Coin of the day
Diffusion Pharmaceuticals Inc. Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Inc.

DFFN
Rang in Aktien #31359
As a biopharmaceutical enterprise, Diffusion Pharmaceuticals Inc. concentrates... As a biopharmaceutical enterprise, Diffusion Pharmaceuticals Inc. concentrates on pioneering new treatments that bolster the body's efficiency in oxygen distribution. The company's flagship investigational therapy is Trans Sodium Crocetinate, which is formulated to facilitate the spread of oxygen into tissues. This compound is additionally under development for its application in addressing COVID-19. Headquartered in Charlottesville, Virginia, Diffusion Pharmaceuticals Inc. was established in 2001.
Aktienkurs
$6.60
Zuletzt synchronisiert: 2023-08-16
Marktkapitalisierung
$13.46M
Veränderung (1 Tag)
11.68%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Diffusion Pharmaceuticals Inc. (DFFN)

Kategorie

Kursverlauf für Diffusion Pharmaceuticals Inc. (DFFN)
Höchster Schlusskurs: $5.14 am 2023-08-01

Niedrigster Schlusskurs: $4.19K am 2016-11-01
Kursverlauf der Aktie von Diffusion Pharmaceuticals Inc. von 2016 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2023 -41.85%
2022 -67.30%
2021 -51.58%
2020 68.95%
2019 -83.84%
2018 -86.17%
2017 -49.59%
2016 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$533.10 36.73%
US
$1.00K 51.34%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE